An international study exploring possible genetic influences on cannabis use disorder (CUD) has identified an association between the disorder and a region of DNA near the FOXP2 gene, previously linked to risk-taking behaviour.

MediPharm Labs Inc has initiated a clinical trial to research and evaluate the effectiveness of the company’s cannabis-derived medicines for the treatment of end-stage renal disease or Chronic Kidney Disease (CKD).

Chronic kidney disease involves kidney damage over a long period of time that impacts on the organ’s ability to filter blood, meaning toxic wastes build up in the body. The progressive condition can result in major complications including eventual kidney failure and death.

Cannabis has been used for its antimicrobial properties for thousands of years, but only recently have these benefits surfaced in Western medicine. A recent study highlights previously unknown antimicrobial properties of cannabis.

While the study focuses on several cannabinoids, it brings out CBG as a cannabinoid to pay attention to in terms of its antibiotic abilities.

What is CBG?

Cannabis use has long been associated with memory loss. But until now, this notion was largely anecdotal. As researchers begin to look into cannabis and the effect that it has on human health, they're beginning to better understand the effect it has on the human brain – and whether cannabis really does impair memory.

Memory is divided into both short-term and long-term memory. Short-term memory is where immediate events are temporarily stored, whereas long-term memory is where information is stored indefinitely.

People with obsessive-compulsive disorder, or OCD, report that the severity of their symptoms was reduced by about half within four hours of smoking cannabis, according to a Washington State University study.

The researchers analyzed data inputted into the Strainprint app by people who self-identified as having OCD, a condition characterized by intrusive, persistent thoughts and repetitive behaviors such as compulsively checking if a door is locked. After smoking cannabis, users with OCD reported it reduced their compulsions by 60%, intrusions, or unwanted thoughts, by 49% and anxiety by 52%.

The end of summer is always a bit of a bummer, what with cooler weather just around the corner.

As the weather turns, people venturing outside will need to forgeto about sandals and swimsuits and opt for more layers. But bulking up is not the only issue; one of the biggest drawbacks of the cooler temperatures might be your skin.

As the weather gets cooler, skin may feel less hydrated than it did all summer, and may experience itchiness, breakouts and even chapping.

Once the weather chills, CBD applied topically has been reported to help with some of skin’s top woes. Here’s why.

A recently published survey report from Medical Cannabis Canada provides a snapshot of medicinal cannabis patients in that country and the challenges they face.

The survey report is based on the responses of a sample of 1,000 patients polled from July 28 to August 1, 2020.

Among the findings, just over half of patients were relatively new to using cannabis medicinally – three years or less. The most common conditions it was being used for were anxiety disorder, depression, and insomnia. As for how much patients were spending each month, for those with a medical document (which was 37%) the figure averaged out to CAD $159.10 and for those without a document, $118.10.

CBD oil can be used to improve your sleep cycle, inflammation, and digestive system and reduce your chances of getting anxiety.

Suffering from anxiety is natural, especially in times like these where a global pandemic has taken the world by storm

The constant and ongoing stressful atmosphere causes serious damage to your body. Apart from that, it destroys your ability to think, focus, and stay calm.

Stress also causes sleep deprivation, loss of energy, and high blood pressure. For people dealing with all these, CBD oil can work as an absolute miracle.

With the help of this product, you can now have the opportunity to a healthy mental condition without any harmful side effects.

More than 40% of patients with multiple sclerosis have used cannabis or cannabinoid products in the last year, according to a study by researchers at the University of Michigan. The study, “Cannabinoid use among Americans with MS: Current trends and gaps in knowledge,” was published recently in Multiple Sclerosis Journal – Experimental, Translational and Clinical.

When Detroit Free Press sports columnist Jeff Seidel noticed a sharp pain between his shoulder blade and spine, he thought he might have overexerted himself at the gym. Or maybe it was old injuries rearing up again.